Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
The choice depends on specific research questions and target tissue types
gastric ulcers, duodenal ulcers, and mucosal erosion where direct local peptide delivery to the damaged tissue is the therapeutic goal Inflammatory bowel conditions: Crohn's disease and ulcerative colitis support, where VEGF-mediated mucosal angiogenesis and anti-inflammatory effects have been investigated Leaky gut and intestinal hyperpermeability: tight junction restoration and mucosal integrity support in patients with compromised gut barrier function Gastroparesis: pro-motility effects via vagal cholinergic pathways investigated in preclinical models of delayed gastric emptying
Bloodbrain barrier breakdown in the aging human hippocampus
The difference comes down to manufacturing environment, formulation specifics, and testing depth
US$ 24.40
US$ 23.48
US$ 28.45
US$ 24.09